← Back to search
EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
Doing business as EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC
GAITHERSBURG, MD, 20879
Unclaimed
Small Business
Prime contracting experience
8 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | IGF::OT::IGF | — | $1,409,725,727 | Aug 18, 2026 | Sep 30, 2016 – Sep 29, 2026 |
| Prime | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM) | — | $857,637,641 | Jun 26, 2026 | Aug 30, 2019 – Sep 30, 2026 |
| Prime | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | MEDICAL COUNTERMEASURES (MCM) THAT CAN BE DEPLOYED IN THE EVENT OF A FILOVIRUS OUTBREAK ARE A CRUCIAL COMPONENT TO THE UNITED STATES GOVERNMENT?S (USG?S) OUTBREAK RESPONSE PLAN. BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA) IS SEEKIN | — | $118,563,679 | Feb 5, 2026 | Jul 31, 2023 – Jul 29, 2033 |
| Prime | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | IGF::OT::IGF FOR OTHER FUNCTIONSTHIS CONTRACT IS FOR THE ADVANCED DEVELOPMENT OF NUTHRAX (ANTHRAX VACCINE ABSORBED WITH CPG 7909) OR AV7909 | — | $43,794,113 | Sep 11, 2024 | Mar 23, 2015 – Jul 31, 2019 |
| Prime | Department of Defense Department of the Army | CREATION OF AN FDA APPROVED ANALGESIC KETAMINE DRUG WITH AUTO INJECTOR DELIVERY SYSTEM. | — | $5,721,771 | Jul 17, 2024 | Sep 26, 2019 – Feb 29, 2024 |
| Prime | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | IGF::OT::IGF - ADVANCING STABILIZED ISOAMYL NITRITE FOR INTRANASAL TREATMENT OF CYANIDE EXPOSURE | — | $32,952,759 | Apr 26, 2024 | Sep 15, 2017 – Jun 3, 2024 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF DEVELOPMENT OF VACCINE FORMULATIONS EFFECTIVE AGAINST NIAID PRIORITY PATHOGENS | — | $30,177,861 | Mar 13, 2023 | Aug 28, 2014 – Feb 29, 2024 |
| Prime | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | TAS::75 0140::TAS ADVANCED DEVELOPMENT OF RECOMBINANT PROTECTIVE ANTIGENT (RPA) ANTHRAX VACCINE CAN 1990087 | — | $92,988,270 | Jul 1, 2022 | Sep 17, 2010 – Jun 9, 2022 |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Agencies supported
- Department of Health and Human ServicesGov-sourced
- Department of DefenseGov-sourced